Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q15708304> ?p ?o }
Showing triples 1 to 29 of
29
with 100 triples per page.
- Q15708304 subject Q8341873.
- Q15708304 subject Q8375173.
- Q15708304 subject Q8546974.
- Q15708304 abstract "AB-005 or [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone is a designer drug offered by online vendors as a cannabimimetic agent. The structure and pharmacological activity of AB-005 was published in 2010, prior to its commercial availability in 2012, where it was reported to have high affinity for both CB1 (Ki = 5.5 nM) and CB2 receptors (Ki = 0.48 nM). AB-005 features groups found in other previously reported synthetic cannabinoids: the tetramethylcyclopropane group of UR-144 and XLR-11 as well as the (1-methyl-2-piperidinyl)methyl substituent of AM-1248 and AM-1220. No information regarding the in vivo activity of AB-005 has been published, and only anecdotal reports are known of its psychoactivity in humans.".
- Q15708304 casNumber "895155-25-6".
- Q15708304 iupacName "[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone".
- Q15708304 thumbnail AB-005.png?width=300.
- Q15708304 wikiPageWikiLink Q1200715.
- Q15708304 wikiPageWikiLink Q21098943.
- Q15708304 wikiPageWikiLink Q419020.
- Q15708304 wikiPageWikiLink Q4646879.
- Q15708304 wikiPageWikiLink Q4649999.
- Q15708304 wikiPageWikiLink Q4652479.
- Q15708304 wikiPageWikiLink Q4652485.
- Q15708304 wikiPageWikiLink Q7865583.
- Q15708304 wikiPageWikiLink Q8042267.
- Q15708304 wikiPageWikiLink Q8341873.
- Q15708304 wikiPageWikiLink Q8375173.
- Q15708304 wikiPageWikiLink Q8546974.
- Q15708304 casNumber "895155".
- Q15708304 iupacName "[1-[methyl]-1H-indol-3-yl]-methanone".
- Q15708304 type ChemicalSubstance.
- Q15708304 type Drug.
- Q15708304 type ChemicalObject.
- Q15708304 type Thing.
- Q15708304 type Q8386.
- Q15708304 comment "AB-005 or [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-methanone is a designer drug offered by online vendors as a cannabimimetic agent. The structure and pharmacological activity of AB-005 was published in 2010, prior to its commercial availability in 2012, where it was reported to have high affinity for both CB1 (Ki = 5.5 nM) and CB2 receptors (Ki = 0.48 nM).".
- Q15708304 label "AB-005".
- Q15708304 depiction AB-005.png.